SelectScience InterviewsLife Sciences

Assay Development for Screening of Therapeutic Transglutaminase Inhibitors

26 May 2016
Assay Development for Screening of Therapeutic Transglutaminase Inhibitors

Dr Andreas Heil, research scientist at Zedira GmbH, describes how BMG Labtech's CLARIOstar® is used to screen inhibitors of transglutaminases for therapeutic applications, such as coeliac disease.

About the company

SelectScience logo

SelectScience

Established in July 1998, SelectScience is the fastest way to impartial, expert opinion about the best laboratory equipment and latest techniques.

Other videos from SelectScience

Links

Assay Development for Screening of Therapeutic Transglutaminase Inhibitors